StockCalc Blog

BridgeBio Pharma (BBIO:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BridgeBio Pharma(BBIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$55.12 (USD) 04/16/2021 Weighted Valuation$37.29 (USD) Overall RatingOvervalued by 32.3% Valuation Models Comparables: $37.29 (USD) Valuation Methods …

BridgeBio Pharma (BBIO:NAS) Fundamental Valuation Report Read more »

Boardwalk REIT (BEI.UN:TSE) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Boardwalk REIT(BEI.UN:TSE) Real Estate:REIT – Residential This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$36.91 (CAD) 04/16/2021 Weighted Valuation$40.60 (CAD) Overall RatingUndervalued by 10.0% Valuation Models Adjusted …

Boardwalk REIT (BEI.UN:TSE) Fundamental Valuation Report Read more »

BeiGene (BGNE:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BeiGene(BGNE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$305.54 (USD) 04/16/2021 Weighted Valuation$289.84 (USD) Overall RatingOvervalued by 5.1% Valuation Models Multiples: $285.42 (USD) Valuation Methods This …

BeiGene (BGNE:NAS) Fundamental Valuation Report Read more »

Brookdale Senior Living (BKD:NYS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Brookdale Senior Living(BKD:NYS) Healthcare:Medical Care Facilities This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.79 (USD) 04/16/2021 Weighted Valuation$9.28 (USD) Overall RatingUndervalued by 36.7% Valuation Models Adjusted …

Brookdale Senior Living (BKD:NYS) Fundamental Valuation Report Read more »

Baker Hughes (BKR:NYS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Baker Hughes(BKR:NYS) Energy:Oil & Gas Equipment & Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.10 (USD) 04/16/2021 Weighted Valuation$19.65 (USD) Overall RatingFairly valued to …

Baker Hughes (BKR:NYS) Fundamental Valuation Report Read more »

BlackLine (BL:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BlackLine(BL:NAS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$119.09 (USD) 04/16/2021 Weighted Valuation$115.54 (USD) Overall RatingFairly valued to slightly Overvalued by 3.0% Valuation Models …

BlackLine (BL:NAS) Fundamental Valuation Report Read more »

BlackRock (BLK:NYS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BlackRock(BLK:NYS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$811.45 (USD) 04/16/2021 Weighted Valuation$776.26 (USD) Overall RatingFairly valued to slightly Overvalued by 4.3% Valuation Models …

BlackRock (BLK:NYS) Fundamental Valuation Report Read more »

BELLUS Health (BLU:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BELLUS Health(BLU:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.58 (USD) 04/16/2021 Weighted Valuation$4.32 (USD) Overall RatingOvervalued by 5.7% Valuation Models Adjusted Book Value: $4.12 (USD) …

BELLUS Health (BLU:NAS) Fundamental Valuation Report Read more »

BELLUS Health (BLU:TSE) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report BELLUS Health(BLU:TSE) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.57 (USD) / $5.72 (CAD) 04/16/2021 Weighted Valuation$4.58 (USD) / $5.73 (CAD) Use a conversion …

BELLUS Health (BLU:TSE) Fundamental Valuation Report Read more »

Boralex (BLX:TSE) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Boralex(BLX:TSE) Utilities:Utilities – Renewable This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$43.56 (CAD) 04/16/2021 Weighted Valuation$44.16 (CAD) Overall RatingFairly valued to slightly Undervalued by 1.4% Valuation Models …

Boralex (BLX:TSE) Fundamental Valuation Report Read more »

Notice to User:

Risk Disclosure:
Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure:
Hypothetical performance results have many inherent limitations, some of which are described below. no representation is being made that any account will or is likely to achieve profits or losses similar to thoseshown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted forin the preparation of hypothetical performance results and all which can adversely affect trading results.

Live Trades Disclosure:
This presentation is for educational purposes only and the opinions expressed are those of the presenter only. All trades presented should be considered hypothetical and should not be expected to be replicated in a live trading account.